Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats

Abstract Background Human umbilical cord mesenchymal stem cells (UCMSCs) transplantation is a promising therapy for the treatment of retinitis pigmentosa (RP). However, intravenously infused cells may be blocked in the lung, increasing the risk of vascular obstruction, which needs to be optimized to...

Full description

Bibliographic Details
Main Authors: Qingling Liang, Qiyou Li, Bangqi Ren, Zheng Qin Yin
Format: Article
Language:English
Published: BMC 2022-02-01
Series:BMC Ophthalmology
Subjects:
Online Access:https://doi.org/10.1186/s12886-021-02171-3
_version_ 1818973779338985472
author Qingling Liang
Qiyou Li
Bangqi Ren
Zheng Qin Yin
author_facet Qingling Liang
Qiyou Li
Bangqi Ren
Zheng Qin Yin
author_sort Qingling Liang
collection DOAJ
description Abstract Background Human umbilical cord mesenchymal stem cells (UCMSCs) transplantation is a promising therapy for the treatment of retinitis pigmentosa (RP). However, intravenously infused cells may be blocked in the lung, increasing the risk of vascular obstruction, which needs to be optimized to further improve safety and efficacy. Methods We derived small UCMSCs (S-UCMSCs) from filtering UCMSCs with a 10-μm filter, and compared with UCMSCs by flow cytometry, directional differentiation culture and transcriptome sequencing. Then the S-UCMSCs and UCMSCs were intravenously infused in the Royal College Surgeons (RCS) rats to evaluate the safety and the efficacy. Results The diameter of S-UCMSCs ranged from 5.568 to 17.231 μm, with an average diameter of 8.636 ± 2.256 μm, which was significantly smaller than that of UCMSCs. Flow cytometry, immunofluorescence and transcriptome sequencing demonstrated that the S-UCMSCs and UCMSCs were the same kind of MSCs, and the S-UCMSCs were more proliferative. After the S-UCMSCs and UCMSCs were intravenously infused into the Royal College of Surgeons (RCS) rats at a dose of 1 × 106 cells/rat, the S-UCMSCs blocked in the lungs were significantly fewer and disappeared more quickly than UCMSCs. The b wave of the flash electroretinogram was improved at 7 d, and the retinal outer nuclear layer thickness was thicker at 7 d and 14 d. The expression level of inflammation was inhibited, and the expression level of neurotrophic factors was upregulated in the retina and serum after transplantation. Conclusions S-UCMSCs intravenous infusion was safer than UCMSCs and could delay retinal degeneration and protect visual function in RCS rats, which may be a preferable therapeutic approach for RP.
first_indexed 2024-12-20T15:29:35Z
format Article
id doaj.art-4a2166d69a3340fca0d6a434f746211c
institution Directory Open Access Journal
issn 1471-2415
language English
last_indexed 2024-12-20T15:29:35Z
publishDate 2022-02-01
publisher BMC
record_format Article
series BMC Ophthalmology
spelling doaj.art-4a2166d69a3340fca0d6a434f746211c2022-12-21T19:35:39ZengBMCBMC Ophthalmology1471-24152022-02-0122111110.1186/s12886-021-02171-3Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS ratsQingling Liang0Qiyou Li1Bangqi Ren2Zheng Qin Yin3Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Amy Medical University)Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Amy Medical University)Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Amy Medical University)Southwest Hospital/Southwest Eye Hospital, Third Military Medical University (Amy Medical University)Abstract Background Human umbilical cord mesenchymal stem cells (UCMSCs) transplantation is a promising therapy for the treatment of retinitis pigmentosa (RP). However, intravenously infused cells may be blocked in the lung, increasing the risk of vascular obstruction, which needs to be optimized to further improve safety and efficacy. Methods We derived small UCMSCs (S-UCMSCs) from filtering UCMSCs with a 10-μm filter, and compared with UCMSCs by flow cytometry, directional differentiation culture and transcriptome sequencing. Then the S-UCMSCs and UCMSCs were intravenously infused in the Royal College Surgeons (RCS) rats to evaluate the safety and the efficacy. Results The diameter of S-UCMSCs ranged from 5.568 to 17.231 μm, with an average diameter of 8.636 ± 2.256 μm, which was significantly smaller than that of UCMSCs. Flow cytometry, immunofluorescence and transcriptome sequencing demonstrated that the S-UCMSCs and UCMSCs were the same kind of MSCs, and the S-UCMSCs were more proliferative. After the S-UCMSCs and UCMSCs were intravenously infused into the Royal College of Surgeons (RCS) rats at a dose of 1 × 106 cells/rat, the S-UCMSCs blocked in the lungs were significantly fewer and disappeared more quickly than UCMSCs. The b wave of the flash electroretinogram was improved at 7 d, and the retinal outer nuclear layer thickness was thicker at 7 d and 14 d. The expression level of inflammation was inhibited, and the expression level of neurotrophic factors was upregulated in the retina and serum after transplantation. Conclusions S-UCMSCs intravenous infusion was safer than UCMSCs and could delay retinal degeneration and protect visual function in RCS rats, which may be a preferable therapeutic approach for RP.https://doi.org/10.1186/s12886-021-02171-3Umbilical cord mesenchymal stem cellsIntravenous infusionSafetyEfficacyRetinitis pigmentosa
spellingShingle Qingling Liang
Qiyou Li
Bangqi Ren
Zheng Qin Yin
Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats
BMC Ophthalmology
Umbilical cord mesenchymal stem cells
Intravenous infusion
Safety
Efficacy
Retinitis pigmentosa
title Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats
title_full Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats
title_fullStr Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats
title_full_unstemmed Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats
title_short Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats
title_sort intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in rcs rats
topic Umbilical cord mesenchymal stem cells
Intravenous infusion
Safety
Efficacy
Retinitis pigmentosa
url https://doi.org/10.1186/s12886-021-02171-3
work_keys_str_mv AT qinglingliang intravenousinfusionofsmallumbilicalcordmesenchymalstemcellscouldenhancesafetyanddelayretinaldegenerationinrcsrats
AT qiyouli intravenousinfusionofsmallumbilicalcordmesenchymalstemcellscouldenhancesafetyanddelayretinaldegenerationinrcsrats
AT bangqiren intravenousinfusionofsmallumbilicalcordmesenchymalstemcellscouldenhancesafetyanddelayretinaldegenerationinrcsrats
AT zhengqinyin intravenousinfusionofsmallumbilicalcordmesenchymalstemcellscouldenhancesafetyanddelayretinaldegenerationinrcsrats